Gilead AI manufacturing hub breaks ground in US, creating over 3,000 jobs and boosting biopharma innovation.
• Gilead begins construction on AI-enabled hub on October 2023.
• Facility spans 180,000 sq ft at California headquarters.
• Creates over 3,000 jobs, boosts US biopharma innovation.
Gilead Sciences has commenced construction on a new AI-enabled manufacturing hub in the Bay Area. The facility, located at Gilead’s headquarters in Foster City, California, is designed to enhance the company’s technical development and manufacturing capabilities. The groundbreaking ceremony was attended by California Lieutenant Governor Eleni Kounalakis. She emphasized the importance of domestic biomanufacturing for strengthening supply chains and creating jobs. Read more about the project here.
The new facility will cover 180,000 square feet and feature advanced digital infrastructure. This includes autonomous robotics and real-time digital monitoring systems. These technologies aim to make the center one of the most AI-enabled in the biopharma industry. Moreover, the facility will include flexible pilot lab space to accelerate technology transfer and support next-generation biologics development.
Why it matters
The construction of this hub is part of Gilead’s $32 billion investment commitment in the United States. The company expects to create more than 3,000 direct and indirect high-quality jobs. Additionally, it aims to deliver $43 billion in economic value. This initiative aligns with the current US administration’s focus on increasing domestic manufacturing investment.
What’s next
Gilead plans to integrate this facility into its broader strategy for delivering next-generation therapies. The company has multiple construction projects underway, all contributing to US leadership in global biopharma innovation. For further insights into Gilead’s strategic initiatives, visit our insights section.